Clinical trial · Interventional
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
NCT04259762CI-TRIAL-00095732completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly less likely to adhere to recommended screening guidelines. The purpose of this trial is to develop and pilot test multilevel/multicomponent intervention strategies to enhance screening for breast, colorectal, and cervical cancers.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Breast | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Cancer, Cervix | Malignant Neoplasm | ALIAS | 0.85 |
| Cancer, Colon | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening
- description
- The study staff will administer to eligible participants the pre-INT and post-INT surveys. The post-INT surveys will be administered approximately 8 months after delivering the INTs. The participants will receive the INT(s) immediately after completing the pre-INT surveys.
- interventionNames
- Other: Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions
Primary outcomes (3)
- measure
- Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers
- timeFrame
- 12 months
- description
- The focus group discussion documents the participants' knowledge about, barriers and support for, and communications about cancer and cancer prevention. Focus group methodology is primarily a qualitative research method and directly quantifying themes is not the typical approach. In this research, only qualitative data were collected with no quantification other than of the number of participants that endorsed a particular theme
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: Breast Cancer Screening Intervention * Women age 45-75 * Average risk for breast cancer * Never had a mammogram OR not had a mammogram within the past 2 years * Residing in the Zuni Pueblo Exclusion Criteria: Breast Cancer Screening Intervention. Meeting at least one of the following criteria: * Women with breast implants, pregnant, or breast feeding * History of breast cancer * Have new breast complaints such as lump or nipple discharge Inclusion Criteria: Colorectal Cancer Screening Intervention * Men and women aged 45-75 * Average risk for colorectal cancer * Never had a fecal occult blood test (FOBT), or fecal immunochemical test (FIT) or a colonoscopy OR not had a FOBT or FIT in the past year, OR no colonoscopy in the past 10 years * Residing in the Zuni Pueblo Exclusion Criteria: Colorectal Cancer Screening Intervention. Meeting at least one of the following criteria: * History of colorectal cancer, total colectomy, adenomatous polyps, or inflammatory bowel disease * Up-to-date with colorectal cancer screening * Severe comorbidity * Incarceration * Family history of colorectal cancer * Hospice/terminal care status Inclusion Criteria: Cervical Cancer Screening Intervention * Women aged 21-65 * Never had a cytology (Pap smear) OR had a Pap smear more than 3 years ago OR women aged 30-75, and never had screening with a combination of cytology and human papillomavirus testing OR no combination of testing in the past 5 years * Residing in the Zuni Pueblo Exclusion Criteria: Cervical Cancer Screening Intervention. Meeting at least one of the following criteria: * History of total hysterectomy * High risk for cervical cancer due to suppressed immune system (e.g., HIV infection, organ transplant, long-term steroid use) * Women over age 65 who have had regular screenings with normal results
References
Publications (0)
Data not yet available
No reference posted for this study.